《大行報告》摩通下調敏實(00425.HK)目標價至38元 評級「增持」
摩根大通發表研究報告,指倘剔除一次性出售收益,敏實集團(00425.HK)上半年業績稍遜預期,電池盒業務令人失望,但管理層指引下半年增長加快,料利潤率有改善;管理層升今年新訂單指引至95億至100億元人民幣,高於原先的介乎75億至80億元人民幣;但收入和盈利指引維持不變,因下半年仍受芯片短缺和原材料成本上升影響。
該行指出,展望明年,管理層相信整體中國產量可按年增10%,海外增長甚至料達20%,維持「增持」評級,目標價由40元降至38元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.